... (Reuters) - The U.S. Supreme Court on
Monday turned away Pfizer Incs......…
...WASHINGTON (Reuters) - The U.S. Supreme Court on Monday turned......…
Pfizer is about to enter a whole new era of growth....…
The negotiation on the 2022 National Medical Insurance Drug Catalogue has officially concluded yesterday (8th), China's National Healthcare Security Administration…
With rates rising, biotech has faded. Investors have favored the pharma stalwarts. Bank of America’s drug analyst Geoff Meacham runs…
...By Julie Zhu and Kevin Huang
HONG KONG/BEIJING (Reuters) - China... told Reuters.
Chinas medical products regulator -…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
BioNTech, which worked with Pfizer to build an mRNA Covid vaccine, has partnered with the U.K. to turn the technology…
Pfizer Gets FDA Priority Review of Prevnar 20 for Kids >PFE...…
...(Changes source, adds Pfizer statement)
Jan 5 (Reuters) - U.S. pharma... disease and oncology," a
spokesperson said in a statement to Reuters,…
...Jan 5 (Reuters) -
* PFIZER SAYS WILL BE SHIFTING TO INVEST IN RARE......…
Drug maker Pfizer Inc. could part with or otherwise distance itself from some of its research programs....…
As part of the shift, the company may sell assets like its gene therapy facility in Durham and a cancer-focused…
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…
Thursdays top analyst upgrades and downgrades included Baidu, Bank of New York Mellon, Charles Schwab, Corning, Livent, Merck, Meta Platforms,…
München (Reuters) - Die stark abflauende Nachfrage nach Corona-Impfstoff setzt dem Arzneimittel-Hersteller Dermapharm zu.
Das Unternehmen aus Grünwald bei München…
Charlotte (www.aktiencheck.de) - Rating-Update:
Geoff Meacham, Analyst von BofA Securities, stuft die Aktie des Pharma-Giganten Pfizer Inc. (ISIN: US7170811035, WKN: 852009,…
Bank of America analysts downgraded the stock to neutral from buy...…
The health care sector held up relatively well in a difficult year for stocks in 2022. On Wednesday, one analyst…
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Der Schub durch Covid-Impfstoffe und Medikamente flaut ab, gleichzeitig läuft für einige Produkte der Patentschutz ab. Novo Nordisk löst Pfizer…
In the latest trading session, Pfizer (PFE) closed at $51.26, marking a +0.04% move from the previous day....…
Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von BioNTech SE (ISIN: US09075V1026,…
Tuesdays top analyst upgrades and downgrades included Ally Financial, Apple, Ardelyx, Block, DocuSign, D.R. Horton, Enovix, EOG Resources, Ford, Futu,…
Deutschland hat sich insgesamt verpflichtet, etwa 375 Millionen Dosen Corona-Impfstoff von BioNTech und dem dazugehörigen amerikanischen Pharma-Partner Pfizer abzunehmen. Das…
BERLIN (dpa-AFX) - Deutschland hat sich insgesamt verpflichtet, etwa 375 Millionen Dosen Corona-Impfstoff von Biontech (BioNTech (ADRs))/Pfizer (Pfizer) abzunehmen. Das…
DUBLIN, Dec. 30, 2022 /PRNewswire/ -- The "Bronchitis Treatments: Global Markets" report has been added to ResearchAndMarkets.coms offering. This study…
San Francisco (www.aktiencheck.de) - Pfizer-Aktienanalyse von Analyst Mohit Bansal von Wells Fargo Advisors:
Mohit Bansal, Analyst von Wells Fargo Advisors, stuft…
Pfizer, Amgen and Bristol-Myers Squibb bought makers of proven drugs ahead of potential rising competition from generics....…
A China-developed Covid antiviral pill appeared to be as effective as Pfizer Inc.s Paxlovid with fewer safety concerns, according to…
The FDA assigns a standard review to Pfizers (PFE) BLA for pentavalent meningococcal vaccine candidate (MenABCWY), with a decision expected…
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced positive results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene…
Pfizer Inc. said Thursday that a Phase 3 study of fidanacogene elaparvovec for the treatment of hemophilia B in adult…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration accepted for review a Biologics License Application or BLA…
Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…
Der Pharma-Riese hat durch die Corona-Pandemie eine Sonderkonjunktur erfahren. Neben dem Covid-19-Medikament Paxlovid sorgte auch der Vertrieb der Corona-Impfstoffe mit…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
DUBLIN, Dec. 28, 2022 /PRNewswire/ -- The "Hormone Replacement Therapy Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation,…
Brazils Ministry of Health has decided to extend the use of Pfizers vaccine against the new coronavirus (Covid-19) to all…
In the latest trading session, Pfizer (PFE) closed at $51.13, marking a -1.35% move from the previous day....…
Hongkong (Reuters) - Chinesen können sich offenbar bald in Hongkong mit dem Impfstoff von BioNTech gegen Covid-19 boostern lassen.
Der…
...Por Reuters Fact Check
26 Dez (Reuters)
…
Berlin (Reuters) - In der Europäischen Union wächst die Sorge vor einem milliardenteuren Überschuss an nicht benötigten Corona-Impfstoffen.
Die Kommission…
ORIC inks a collaboration deal with Pfizer for a phase II study evaluating ORIC-533 in combination with the latters elranatamab…
Shares of Oric Pharmaceuticals Inc. soared about 56% in premarket trading on Thursday, the day after the company said…
NEW YORK CITY (dpa-AFX) - ORIC Pharmaceuticals Inc. (ORIC) said that it has reached a clinical development collaboration with Pfizer…
Pfizer (PFE) closed at $51.66 in the latest trading session, marking a +0.66% move from the prior day....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…